We are pleased to share the launch of the CANCERSurvey 2026, a pan-European patient experience survey led by the European Cancer Organisation (ECO) and WeCanAdvocate.
This important initiative aims to gather the experiences of 10,000 people affected by cancer across Europe, creating robust, comparable evidence that will help shape future cancer policies, improve healthcare services, and strengthen patient advocacy efforts.
Who can participate?
The survey is open to:
- Adult people living with or who have been diagnosed with cancer
- Cancer survivors
- Caregivers completing the survey on behalf of a patient (where appropriate)
Participants must reside in Europe.
About the Survey
- Launch: 1 September 2026
- Closing date: 16 November 2026
- Available in: 15 European languages
- Time to complete: Approximately 25 minutes
The survey explores the real-life experiences of people affected by cancer, providing valuable insights into access to care, treatment experiences, quality of life, and the challenges patients face throughout their cancer journey.
Why Your Participation Matters
Every response contributes to a stronger evidence base for advocacy across Europe.
The findings will help:
- Inform European and national cancer policies
- Identify inequalities in cancer care and patient experiences
- Strengthen the voice of people living with cancer
- Support advocacy efforts aimed at improving access to high-quality care and patient-centred services
By participating, you can help ensure that the experiences of people living with Chronic Myeloid Leukemia (CML) are represented alongside those of the wider cancer community.
Take Part
The survey will be available from 1 September 2026.
Learn more about the project:
https://wecanadvocate.eu/projects-and-initiatives/cancersurvey/
We encourage all members of the CML community to participate and to share the survey within their local networks once it launches.
Together, we can help ensure that the patient voice continues to shape the future of cancer care across Europe.
